TransPerfect
, a leading provider of e-clinical technologies to the
life sciences
industry, today announced that
Worldwide Clinical Trials
(WCT) has selected
Trial Interactive
as its electronic Trial Master File (eTMF) solution to streamline global study management. Trial Interactive is a web-based, 21 CFR Part 11 compliant platform that eliminates the redundancies inherent in paper-based TMF studies.
“With Trial Interactive as our eTMF solution, we will be able to deliver near real-time access to eTMFs for our clients, and we will improve overall processes in managing TMF documentation,” said Tom Wardle, Chief Operating Officer of WCT.
By providing study stakeholders with real-time access to
clinical trial documentation
, Trial Interactive eliminates travel and shipping costs associated with review and reconciliation, thereby streamlining clinical development programs for WCT and its sponsors. In addition, Trial Interactive’s interface is available in more than 20 languages, which will enable WCT to deploy the solution in the local language of the end user, including global study teams, sponsors, and investigative site personnel.
Michael Smyth, General Manager of TransPerfect Life Sciences Solutions, added, “We are proud that WCT has chosen Trial Interactive as its eTMF solution, and we’re pleased to support their ultimate goal of a paperless clinical trial.”
Gilead Shares Final Data from Phase III MYR301 Trial of Bulevirtide in Chronic Hepatitis Delta Virus
May 7th 2025Long-term results from the study show 90% of patients with chronic HDV who achieved undetectable HDV RNA at 96 weeks of treatment remained undetectable for nearly 2 years post-treatment.
Unifying Industry to Better Understand GCP Guidance
May 7th 2025In this episode of the Applied Clinical Trials Podcast, David Nickerson, head of clinical quality management at EMD Serono; and Arlene Lee, director of product management, data quality & risk management solutions at Medidata, discuss the newest ICH E6(R3) GCP guidelines as well as how TransCelerate and ACRO have partnered to help stakeholders better acclimate to these guidelines.